Idiopathic pulmonary fibrosis;Fibrose pulmonaire idiopathique

Presse Medicale

Volumn 37, Issue 11, 2008, Pages 1581-1590

  Cottin, Vincent ^a   Cordier, Jean François ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; PREDNISONE;

DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EMPHYSEMA; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; PATHOPHYSIOLOGY; RISK FACTOR; SHORT SURVEY;

BIOPSY; BRONCHOALVEOLAR LAVAGE; FIBROBLASTS; HUMANS; LUNG; PROGNOSIS; PULMONARY FIBROSIS; RISK FACTORS; THORACIC SURGERY, VIDEO-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 54949101127     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.01.024     Document Type: Short Survey

References (51)

1. Selman M., King Jr. T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134 2 (2001) 136-151
2. Selman M., and Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res (2002) 10-33
3. Fang K.C. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am J Respir Cell Mol Biol 23 2 (2000) 142-145
4. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114 3 (2004) 438-446
5. Hashimoto N., Jin H., Liu T., Chensue S.W., and Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 2 (2004) 243-252
6. Cool C.D., Groshong S.D., Rai P.R., Henson P.M., Stewart J.S., and Brown K.K. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 174 6 (2006) 654-658
7. Falfan-Valencia R., Camarena A., Juarez A., Becerril C., Montano M., Cisneros J., et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum Genet 118 2 (2005) 235-244
8. Grutters J.C., and du Bois R.M. Genetics of fibrosing lung diseases. Eur Respir J 25 5 (2005) 915-927
9. Taskar V.S., and Coultas D.B. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 3 4 (2006) 293-298
10. Steele M.P., Speer M.C., Loyd J.E., Brown K.K., Herron A., Slifer S.H., et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 172 9 (2005) 1146-1152
11. Steele M.P., and Brown K.K. Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration 74 6 (2007) 601-608
12. Armanios M.Y., Chen J.J., Cogan J.D., Alder J.K., Ingersoll R.G., Markin C., et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356 13 (2007) 1317-1326
13. Tsakiri K.D., Cronkhite J.T., Kuan P.J., Xing C., Raghu G., Weissler J.C., et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 104 18 (2007) 7552-7557
14. Hodgson U., Pulkkinen V., Dixon M., Peyrard-Janvid M., Rehn M., Lahermo P., et al. ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis. Am J Hum Genet 79 1 (2006) 149-154
15. Cottin V., Capron F., Grenier P., and Cordier J.F. Pneumopathies interstitielles diffuses idiopathiques. Classification de Consensus International Multidisciplinaire de l'American Thoracic Society et de l'European Respiratory Society, principales entités anatomo-cliniques, et conduite du diagnostic. Rev Mal Respir 21 (2004) 299-318
16. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002; 165(2):277-304.
17. Cottin V., Donsbeck A.V., Revel D., Loire R., and Cordier J.F. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 158 4 (1998) 1286-1293
18. Katzenstein A.L.A., and Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histological features and clinical significance. Am J Surg Pathol 18 2 (1994) 136-147
19. Flaherty K.R., and Martinez F.J. Nonspecific interstitial pneumonia. Semin Respir Crit Care Med 27 6 (2006) 652-658
20. Kinder B.W., Collard H.R., Koth L., Daikh D.I., Wolters P.J., Elicker B., et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?. Am J Respir Crit Care Med 176 7 (2007) 691-697
21. Flaherty K.R., King Jr. T.E., Raghu G., Lynch III J.P., Colby T.V., Travis W.D., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170 8 (2004) 904-910
22. King Jr. T.E., Tooze J.A., Schwarz M.I., Brown K.R., and Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164 7 (2001) 1171-1181
23. Flaherty K.R., Mumford J.A., Murray S., Kazerooni E.A., Gross B.H., Colby T.V., et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168 5 (2003) 543-548
24. Jegal Y., Kim D.S., Shim T.S., Lim C.M., Do Lee S., Koh Y., et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 171 6 (2005) 639-644
25. Lama V.N., Flaherty K.R., Toews G.B., Colby T.V., Travis W.D., Long Q., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168 9 (2003) 1084-1090
26. Nadrous H.F., Pellikka P.A., Krowka M.J., Swanson K.L., Chaowalit N., Decker P.A., et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 128 4 (2005) 2393-2399
27. Lettieri C.J., Nathan S.D., Barnett S.D., Ahmad S., and Shorr A.F. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129 3 (2006) 746-752
28. Le Jeune I., Gribbin J., West J., Smith C., Cullinan P., and Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101 12 (2007) 2534-2540
29. King Jr. T.E., Schwarz M.I., Brown K., Tooze J.A., Colby T.V., Waldron Jr. J.A., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 6 (2001) 1025-1032
30. Antoniou K.M., Hansell D.M., Rubens M.B., Marten K., Desai S.R., Siafakas N.M., et al. Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status. Am J Respir Crit Care Med 177 2 (2008) 190-194
31. Collard H.R., Moore B.B., Flaherty K.R., Brown K.K., Kaner R.J., King Jr. T.E., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176 7 (2007) 636-643
32. Kim D.S., Park J.H., Park B.K., Lee J.S., Nicholson A.G., and Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27 1 (2006) 143-150
33. Cottin V., Nunes H., Brillet P.Y., Delaval P., Devouassoux G., Tillie-Leblond I., et al., and the Groupe d'Etude et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 26 4 (2005) 586-593
34. Cottin V., Brillet P.Y., Nunes H., and Cordier J.F. Syndrome d'emphysème des sommets et fibrose pulmonaire des bases combinés. Presse Med 36 6 Pt 2 (2007) 936-944
35. Thabut G., Mal H., Castier Y., Groussard O., Brugiere O., Marrash-Chahla R., et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126 2 (2003) 469-475
36. Flaherty K.R., Toews G.B., Lynch III J.P., Kazerooni E.A., Gross B.H., Strawderman R.L., et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 110 4 (2001) 278-282
37. Hope-Gill B.D., Hilldrup S., Davies C., Newton R.P., and Harrison N.K. A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 8 (2003) 995-1002
38. Raghu G., Depaso W.J., Cain K., Hammar S.P., Wetzel C.E., Dreis D.F., et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo- controlled clinical trial. Am Rev Respir Dis 144 2 (1991) 291-296
39. Johnson M.A., Kwan S., Snell N.J., Nunn A.J., Darbyshire J.H., and Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 44 4 (1989) 280-288
40. Members of the Lung Study Group, Douglas W.W., Ryu J.H., Swensen S.J., Offord K.P., Schroeder D.R., Caron G.M., et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Am J Respir Crit Care Med 158 1 (1998) 220-225
41. Collard H.R., Ryu J.H., Douglas W.W., Schwarz M.I., Curran-Everett D., King Jr. T.E., et al. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest 125 6 (2004) 2169-2174
42. Raghu G., Lasky J.A., Costabel U., Brown K.K., Cottin V., Thomeer M., et al. A randomized placebo controlled trial assessing the efficacy and safety of etanercept in patients with idiopathic pulmonary fibrosis (IPF). Chest 128 4 (2005) 496s
43. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353 21 (2005) 2229-2242
44. Ziesche R., Hofbauer E., Wittmann K., Petkov V., and Block L.H. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med (1999) 3411264-3411269
45. Raghu G., Brown K.K., Bradford W.Z., Starko K., Noble P.W., Schwartz D.A., et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350 2 (2004) 125-133
46. Azuma A., Nukiwa T., Tsuboi E., Suga M., Abe S., Nakata K., et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171 9 (2005) 1040-1047
47. King Jr. T.E., Behr J., Brown K.K., Du Bois R.M., Lancaster L., de Andrade J.A., et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 177 1 (2008) 75-81
48. Lynch D.A., Behr J., Brown K.K., Du Bois R.M., King Jr. T.E., and Raghu G. High-resolution computed tomography (HRCT) features correlate with response to bosentan in idiopathic pulmonary fibrosis (IPF): the BUILD1 study. Proc Am Thorac Soc (2007) 175A567
49. Ambrosini V., Cancellieri A., Chilosi M., Zompatori M., Trisolini R., Saragoni L., et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 22 5 (2003) 821-826
50. Kubo H., Nakayama K., Yanai M., Suzuki T., Yamaya M., Watanabe M., et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 128 3 (2005) 1475-1482
51. Raghu G., Yang S.T., Spada C., Hayes J., and Pellegrini C.A. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 129 3 (2006) 794-800